Thursday| 7 March 2024 | DAY THREE

_____________________________________________________________

8:30-9:00 | Registration

9:00-9:10 | Announcements and Housekeeping

• Karl Salwedel, PhD, Division of AIDS, NIAID, NIH, USA

9:10-9:30 | Welcome form the AIDS Panel Chairs

• Akifumi Takaori-Kondo, MD, PhD, Kyoto University
• Thomas Hope, PhD, Northwestern University

9:30-10:00 | Novel Host Factors Regulating HIV-1 Latency

• Akifumi Takaori-Kondo, MD, PhD, Kyoto University

_____________________________________________________________

SESSION ONE: Data Science / AI and Emerging Technologies

10:00-10:30 | Mobilizing Integrated Organ Immunity Against HIV | Bali Pulendran, PhD, Stanford University

10:30-11:00 | Identification of Host Factors Regulating HIV-1 Latency and Their Potential Therapeutic Targets in HIV-1 Latency Reversal | Hiroaki Takeuchi, PhD, Tokyo Medical and Dental University

_____________________________________________________________

10:30-11:00 | Coffee Break 

_____________________________________________________________

11:00 - 11:30 | Distinctive Attributes of HIV-Infected CD4 T Cells under ART Revealed by Microfluidics-Assisted Sorting and Whole Transcriptome Sequencing | Eli Boritz, PhD, National Institute of Allergy and Infectious Diseases, NIH (virtual)

11:30 - 12:00 | Molecular profiling of the SIV tissue reservoirs microenvironment at a single focus level during ART and post-ATI | Ramon Lorenzo-Redondo, PhD, Northwestern University

12:00 - 12:30 | Characterization of the active HIV reservoir from ART-suppressed people with HIV | Nadia Roan, PhD, Gladstone Institutes; University of California, San Francisco (UCSF)

_____________________________________________________________

12:30-13:30 | Lunch Break

_____________________________________________________________

SESSION TWO: Viral Eradication and Control

1:30 - 2:00 | In vitro Studies for the Development of Drug-based Therapies for HIV Reservoirs | Kenji Maeda, MD, PhD, Kagoshima University

2:00 - 2:30 | The Role of SIV-specific follicular CD8 T Cells during Chronic SIV Infection | Takuya Yamamoto, PhD, National Institutes of Biomedical Innovation, Health and Nutrition

_____________________________________________________________

SESSION THREE: HIV Prevention Science

2:30 - 3:00 | Targeting Specificity of SIV-specific B-cell Responses | Hiroyuki Yamamoto, MD, PhD, National Institute of Infectious Diseases

3:00 - 3:30 | Beyond the Science: Going from Need to Impact with an HIV Vaccine | Jerome Kim, MD, International Vaccine Initiative, Seoul, South Korea

_____________________________________________________________